AstraZeneca’s coronavirus vaccine suffered a setback that shows why Big Pharma would rather be safe than sorry. Here’s the good news.

2020-09-09

  U.K.-based pharmaceutical giant AstraZeneca said Tuesday it will suspend clinical trials of a coronavirus vaccine it developed with Oxford University after a British subject fell ill. The decision will affect the company’s just-started so-called Phase 3 trial, which recruited 30,000 volunteers in the U.S. after 10,000 subjects in theRead More →

CrowdStrike stock retreats following coronavirus-fueled earnings beat

2020-09-02

  MARKETWATCH PHOTO ILLUSTRATION/ISTOCKPHOTO|, CROWDSTRIKE CrowdStrike Holdings Inc.  shares retreated from 2020’s meteoric rise in the extended session Wednesday after the cloud-based cybersecurity company topped Wall Street estimates, with more businesses seeking to protect their systems as employees work from home. On a conference call, CrowdStrike CRWD, -1.12% co-founder andRead More →

‘Black Swan’ author says if investors don’t use a ‘tail hedge,’ he recommends ‘not being in the market’—‘We’re facing a huge amount of uncertainty’

2020-06-27

“ ‘If you don’t have a tail hedge, I suggest not being in the market we’re facing a huge amount of uncertainty.’  ” That’s “Black Swan: The Impact of the Highly Improbable” author Nassim Nicholas Taleb offering his view on the risks swirling in the market and a growing lack of clarityRead More →

What financial advisers have been doing with their clients’ money since the pandemic started and people search LESS for jobs after they exhaust their unemployment benefits

2020-06-24

Stay safe, MarketWatchers, and don’t miss these top stories: Personal finance Almost 1 in 3 Americans feel less patriotic this July 4th Fewer people are celebrating the Fourth of July or spending money on the holiday this year, surveys find What financial advisers have been doing with their clients’ moneyRead More →